Migraine Pathophysiology: The Role of Blood Vessel Dilation and Neurovascular Mechanisms

Current Understanding

Migraine is a primary headache disorder involving genetic susceptibility, cortical hyperexcitability, and neurovascular activation. Vascular changes are part of the cascade but not the sole driver.

Key Mechanisms Linking Vasodilation to Migraine

1. Trigeminovascular Activation

Trigeminal nerve endings around meningeal vessels release CGRP, substance P, PACAP → vasodilation, plasma extravasation, mast cell degranulation → sterile inflammation → sensitization of central neurons.

2. Cortical Spreading Depression (CSD)

Wave of neuronal/glial depolarization spreads across cortex (underlies aura). Activates trigeminal afferents and alters cerebral blood flow (initial hyperemia then oligemia).

3. Cerebral Blood Flow Changes

During attacks: increased flow in brainstem (trigeminal nucleus caudalis) and cortical areas. Whether dilation causes pain or reflects neuronal activity remains debated.

4. Neurogenic Inflammation

Meningeal inflammation mediated by neuropeptides causes further vasodilation and sensitization—a feed-forward loop.

Therapeutic Implications

  • Triptans: 5-HT1B/1D agonists → vasoconstriction + inhibit neuropeptide release.
  • CGRP monoclonal antibodies/gepants: Block CGRP signaling without direct vasoconstriction—safer in cardiovascular disease.
  • Lasmiditan: 5-HT1F agonist (no vascular effects).

Beyond Vessels

Genetics (CACNA1A, ATP1A2, SCN1A), hormonal triggers, sleep disruption, sensory stimuli, and central sensitization all contribute. A holistic biopsychosocial approach optimizes management.

Migraine - Related Articles